Skip to content

Clinical trials

Phase 2/3 Pancreatic Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 2/3 Country / region: China Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20141
20171
20182
20201
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Unknown status3
Active, not recruiting1
Not yet recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fudan University2
Tianjin Medical University Cancer Institute and Hospital2
1Globe Health Institute LLC1
Bristol-Myers Squibb1
Chinese University of Hong Kong1
Hutchmed1
Pfizer1
RenJi Hospital1
Ruijin Hospital1
Second Affiliated Hospital of Guangzhou Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms12
Anorexia1
Breast Neoplasms1
Cachexia1
Carcinoma, Hepatocellular1
Colonic Neoplasms1
Fatigue1
Head and Neck Neoplasms1
Kidney Neoplasms1
Lung Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.